Regeneron Pharmaceuticals, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

92,461

Value ($000)

71,368

Weight

0.1%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	71,368	0.1%	92,461	12/31/2025
2025 Q3	11/14/2025	106,930	0.2%	190,176	9/30/2025
2025 Q2	8/14/2025	86,148	0.1%	164,092	6/30/2025
2025 Q1	5/14/2025	96,059	0.2%	151,458	3/31/2025
2024 Q4	2/14/2025	58,548	0.1%	82,192	12/31/2024
2024 Q3	11/14/2024	35,227	0.1%	33,510	9/30/2024
2024 Q2	8/15/2024	31,964	0.1%	30,412	6/30/2024
2024 Q1	5/7/2024	35,586	0.1%	36,973	3/31/2024
2023 Q4	2/14/2024	79,219	0.1%	90,197	12/31/2023
2023 Q3	11/14/2023	45,148	0.1%	54,860	9/30/2023
2023 Q2	8/11/2023	53,184	0.1%	74,017	6/30/2023
2023 Q1	5/16/2023	79,048	0.1%	96,204	3/31/2023
2022 Q4	2/14/2023	58,078	0.1%	80,497	12/31/2022
2022 Q3	11/14/2022	15,942	0.0%	23,142	9/30/2022
2022 Q2	8/15/2022	28,818	0.1%	48,751	6/30/2022
2022 Q1	5/16/2022	42,822	0.1%	61,312	3/31/2022
2021 Q4	2/14/2022	111,163	0.2%	176,023	12/31/2021
2021 Q3	11/15/2021	163,497	0.2%	270,163	9/30/2021
2021 Q2	8/11/2021	200,140	0.2%	358,327	6/30/2021
2021 Q1	5/17/2021	101,323	0.1%	214,152	3/31/2021
2020 Q4	2/16/2021	344,380	0.5%	712,841	12/31/2020
2020 Q3	11/16/2020	108,883	0.2%	194,510	9/30/2020
2020 Q2	8/14/2020	65,047	0.1%	104,300	6/30/2020
2020 Q1	5/15/2020	17,204	0.0%	35,233	3/31/2020
2019 Q4	2/14/2020	24,019	0.0%	63,969	12/31/2019
2014 Q1	5/14/2014	78,665	0.2%	261,975	3/31/2014
2013 Q4	2/13/2014	53,558	0.1%	194,588	12/31/2013